BioCentury | Sep 29, 2016
Emerging Company Profile

Composite T cells

...Number of employees: 10 Funds raised: €7 million ($7.81 million) Investors: Medicxi Ventures, Baxalta Ventures, Utrecht Holdings...
BioCentury | Apr 4, 2016
Finance

Medicxi's platform exception

...in a series A round led by Medicxi and Baxalta Ventures. Gadeta's founders, management and Utrecht Holdings...
BioCentury | Mar 30, 2016
Financial News

Gadeta raises EUR 7M for T cell therapies

...a series A round led by Baxalta Ventures and Medicxi Ventures. Gadeta's founders, management and Utrecht Holdings...
...to start a second clinical study in solid tumors later in 2017. Gadeta's co-founders include Utrecht Holdings...
BioCentury | Sep 29, 2011
Distillery Therapeutics

Indication: Cancer

...Sept. 29, 2011 Patent application filed; contact Utrecht Holdings B.V. for licensing details Contact: Oscar Schoots, Utrecht Holdings...
BioCentury | Aug 7, 2008
Distillery Techniques

This Week in Techniques

...delivery and targeted imaging of neural inflammatory processes. Patent application filed; available for licensing through Utrecht Holdings...
BioCentury | May 4, 1998
Company News

U-BiSys, University of Utrecht deal

The university created Utrecht Holding NV to transfer technology developed at the university to U-BiSys, which develops antibody-based delivery technology for bioactive compounds to intervene in chronic immune responses and to combat cancer. Under the...
Items per page:
1 - 6 of 6
BioCentury | Sep 29, 2016
Emerging Company Profile

Composite T cells

...Number of employees: 10 Funds raised: €7 million ($7.81 million) Investors: Medicxi Ventures, Baxalta Ventures, Utrecht Holdings...
BioCentury | Apr 4, 2016
Finance

Medicxi's platform exception

...in a series A round led by Medicxi and Baxalta Ventures. Gadeta's founders, management and Utrecht Holdings...
BioCentury | Mar 30, 2016
Financial News

Gadeta raises EUR 7M for T cell therapies

...a series A round led by Baxalta Ventures and Medicxi Ventures. Gadeta's founders, management and Utrecht Holdings...
...to start a second clinical study in solid tumors later in 2017. Gadeta's co-founders include Utrecht Holdings...
BioCentury | Sep 29, 2011
Distillery Therapeutics

Indication: Cancer

...Sept. 29, 2011 Patent application filed; contact Utrecht Holdings B.V. for licensing details Contact: Oscar Schoots, Utrecht Holdings...
BioCentury | Aug 7, 2008
Distillery Techniques

This Week in Techniques

...delivery and targeted imaging of neural inflammatory processes. Patent application filed; available for licensing through Utrecht Holdings...
BioCentury | May 4, 1998
Company News

U-BiSys, University of Utrecht deal

The university created Utrecht Holding NV to transfer technology developed at the university to U-BiSys, which develops antibody-based delivery technology for bioactive compounds to intervene in chronic immune responses and to combat cancer. Under the...
Items per page:
1 - 6 of 6